£72m of funding has been announced to establish 14 new Commercial Research Delivery Centres (CRDCs) across England.
The investment, beginning in April 2025 and running for 7 years, is awarded from the £400 million Voluntary Scheme for Branded Medicine Pricing, Access, Growth (VPAG) Investment Programme (VPAG is a partnership between the UK Government and the pharmaceutical industry), and NIHR in England.
It is intended that the CRDCs will enhance the speed and efficiency of commercial clinical research delivery, and support the decentralisation of clinical trials to smaller district general hospitals and primary care settings.
In addition to the CRDCs in England, there will be four in Scotland, and a one nation approach in Wales and Northern Ireland.
You can find out more here: https://www.nihr.ac.uk/news/ps72m-boost-commercial-research-benefit-health-nation